SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-127421
Filing Date
2011-05-05
Accepted
2011-05-05 08:30:31
Documents
13
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 574008
2 NON-EMPLOYEE DIRECTORS' EQUITY INCENTIVE PLAN dex101.htm EX-10.1 48656
3 FORM OF NON-EMPLOYEE DIRECTORS' EQUITY INCENTIVE PLAN dex102.htm EX-10.2 34249
4 FORM OF 2009 EQUITY INCENTIVE PLAN dex103.htm EX-10.3 33198
5 AMENDMENT TO EXENATIDE MANUFACTURING AGREEMENT dex104.htm EX-10.4 15497
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex311.htm EX-31.1 9872
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex312.htm EX-31.2 9680
8 CERTIFICATIONS PURSUANT TO U.S.C. SECTION 1350 dex321.htm EX-32.1 4294
  Complete submission text file 0001193125-11-127421.txt   2543590

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT amln-20110331.xml EX-101.INS 324787
10 XBRL TAXONOMY EXTENSION SCHEMA amln-20110331.xsd EX-101.SCH 17690
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amln-20110331_cal.xml EX-101.CAL 35569
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE amln-20110331_lab.xml EX-101.LAB 129827
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amln-20110331_pre.xml EX-101.PRE 79571
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 11812560
SIC: 2834 Pharmaceutical Preparations